HANGZHOU, Dec. 10 (Xinhua) -- Chinese scientists have harnessed one of the human body's fastest and strongest immune responses to develop a potential...
Vous n'êtes pas connecté
Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 19/11/2024 13:53
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the genetic material of living organisms. One application is in cell therapy: a patient’s immune cells can be specifically reprogrammed to fight cancer more effectively. Researchers in the Department of Biosystems Science and Engineering at ETH Zurich [...]
HANGZHOU, Dec. 10 (Xinhua) -- Chinese scientists have harnessed one of the human body's fastest and strongest immune responses to develop a potential...
HANGZHOU, Dec. 10 (Xinhua) -- Chinese scientists have harnessed one of the human body's fastest and strongest immune responses to develop a potential...
Children born with ADA SCID can develop strong functioning immune systems after a single course of gene corrected stem cell therapy, transforming...
Reducing calorie intake helps cancer-fighting immune cells do their jobs more effectively, reports a study by Van Andel Institute scientists and...
Reducing calorie intake helps cancer-fighting immune cells do their jobs more effectively, reports a study by Van Andel Institute scientists and...
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street...
Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling...
Key Highlights Motixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling...
BEIJING, Dec. 2 (Xinhua) -- A research team at the Wuhan University of Science and Technology (WUST) has recently developed a new targeted delivery...
BEIJING, Dec. 2 (Xinhua) -- A research team at the Wuhan University of Science and Technology (WUST) has recently developed a new targeted delivery...